Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation

被引：28
|
作者：
Van Bömmel, F [1 ]
Schernick, A [1 ]
Hopf, U [1 ]
Berg, T [1 ]
机构：
[1] Humboldt Univ, Charite, Med Klin Scherpunkt Hepatol & Gastroenterol, Berlin, Germany
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 02期
关键词：
D O I：
10.1053/gast.2003.1240586b
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：586 / 587
页数：2
相关论文
共 50 条
  • [31] MULTICENTER RANDOMIZED CONTROLLED TRIAL OF SWITCHING TO TENOFOVIR DISOPROXIL FUMARATE MONOTHERAPY IN LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B PATIENTS WITH UNDETECTABLE HBV VIRAL LOAD UNDER LAMIVUDINE/ADEFOVIR ADD-ON THERAPY: INTERIM ANALYSIS
    Huang, Y. -H.
    Yu, M. -L.
    Peng, C. -Y.
    Chen, J. -J.
    Chen, C. -Y.
    Su, C. -W.
    Lin, W. -Y.
    Lai, H. -C.
    Wang, Y. -J.
    Dai, C. -Y.
    Chuang, W. -L.
    Lin, H. -C.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S605 - S605
  • [32] Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication
    van Bömmel, F
    Wünsche, T
    Schürmann, D
    Berg, T
    HEPATOLOGY, 2002, 36 (02) : 507 - 508
  • [33] Randomized Controlled Trial of Switching to Tenofovir Disoproxil Fumarate Monotherapy in Lamivudine-Resistant Chronic Hepatitis B Patients with Undetectable HBV Viral Load under Lamivudine/-Adefovir Add-on Therapy: The First Interim Analysis
    Huang, Yi-Hsiang
    Su, Chien-Wei
    Wang, Yuan-Jen
    Huang, Yi-Shin
    Lee, Kuei-Chuan
    Hou, Ming-Chih
    Lin, Han-Chieh
    HEPATOLOGY, 2014, 60 : 1108A - 1109A
  • [34] Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
    Patterson, S. J.
    George, J.
    Strasser, S. I.
    Lee, A. U.
    Sievert, W.
    Nicoll, A. J.
    Desmond, P. V.
    Roberts, S. K.
    Locarnini, S.
    Bowden, S.
    Angus, P. W.
    GUT, 2011, 60 (02) : 247 - 254
  • [35] A comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus (HBV) infection.
    van Bömmel, F
    Wünsche, T
    Schürmann, D
    Bergk, A
    Wiedenmann, B
    Hopf, U
    Berg, T
    HEPATOLOGY, 2003, 38 (04) : 275A - 275A
  • [36] Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics
    Hsu, Yao-Chun
    Wei, Mike T.
    Nguyen, Mindie H.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (11) : 999 - 1008
  • [37] The antiviral response to tenofovir disoproxil fumarate (TDF) is comparable in lamivudine (LAM)-naive and LAM-experienced subjects treated for chronic hepatitis B (CHB)
    Manns, M.
    Jeffers, L.
    Dalekos, G.
    Berg, T.
    Trepo, C.
    Roberts, S.
    Prieto, M.
    Rizzetto, M.
    Sorbel, J.
    Anderson, J.
    Mondou, E.
    Rousseau, F.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S33 - S33
  • [38] Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B
    Suzuki, Kazuharu
    Suda, Goki
    Yamamoto, Yoshiya
    Abiko, Satoshi
    Kinoshita, Kenji
    Miyamoto, Shuichi
    Sugiura, Ryo
    Kimura, Megumi
    Maehara, Osamu
    Yamada, Ren
    Kitagataya, Takashi
    Shigesawa, Taku
    Ohara, Masatsugu
    Kawagishi, Naoki
    Nakai, Masato
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    PLOS ONE, 2022, 17 (01):
  • [39] Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study
    Fung, Scott
    Kwan, Peter
    Fabri, Milotka
    Horban, Andrzej
    Pelemis, Mijomir
    Hann, Hie-Won
    Gurel, Selim
    Caruntu, Florin A.
    Flaherty, John F.
    Massetto, Benedetta
    Kim, Kyungpil
    Kitrinos, Kathryn M.
    Subramanian, G. Mani
    McHutchison, John G.
    Yee, Leland J.
    Elkhashab, Magdy
    Berg, Thomas
    Sporea, Loan
    Yurdaydin, Cihan
    Husa, Petr
    Jablkowski, Maciej S.
    Gane, Edward
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : 11 - 18
  • [40] The antiviral response to tenofovir disoproxil fumarate (TDF) is comparable in lamivudine (LAM)-naive and LAM-experienced subjects treated for chronic hepatitis B (CHB)
    Afdhal, Nezam
    Manus, Michael P.
    Jeffers, Lennox J.
    Nguyen, Tuan
    Berg, Thomas
    Dalekos, Georgios N.
    Trepo, Christian
    Roberts, Stuart K.
    Prieto, Martin
    Sorbel, Jeff
    Anderson, Jane
    Mondou, Elsa
    Rousseau, Franck
    GASTROENTEROLOGY, 2008, 134 (04) : A809 - A809
12345